| Date | Title | Description |
| 27.03.2026 | Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) | Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
Fri, Mar 27, 2026 08:00 CET Report this content
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual Ge... |
| 20.11.2024 | The Healthcare Technology Report Announces The Top 100 Healthcare Technology Companies of 2024 | The Healthcare Technology Report
The Healthcare Technology Report is pleased to announce its annual awards for The Top 100 Healthcare Technology Companies.
NEW YORK, Nov. 20, 2024 /PRNewswire-PRWeb/ -- The Healthcare Technology Report is pl... |
| 15.03.2024 | HiLabs closes $39 million Series B financing | HiLabs a leading provider of AI-powered solutions to clean dirty data, unlocking its hidden potential for healthcare transformation closed a $39 million Series B financing.
The round was led by our Eight Roads Ventures India team and Denali... |
| 11.03.2024 | Thanks to AI, this start-up wants to revolutionize pharmaceutical research | - |
| 17.01.2024 | Eleos Health Grows Behavioral Health AI Product Offerings, Expands Reach to 25 States | - |
| 16.11.2023 | Eight Roads HiBob Young Generation in Tech Report | For the second year running, we've launched 'The Young Generation in Tech' report together with our portfolio company HiBob - the global HR tech platform.
Attracting and retaining young talent is vital to European tech. We surveyed 2,000 20... |
| 12.07.2023 | What’s Wrong With Nvidia, And What To Do About It | 2021/07/15: In this photo illustration the stock trading graph of Nvidia Corporation seen on a ... [+] smartphone screen. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Imag... |
| 29.05.2023 | Toronto-based AI startup BenchSci raises USD 70 million in Series D funding | TORONTO—A USD 70 million Series D funding round led by Generation Investment Management and including current investors iNovia Capital, TCV, Golden Ventures, and F-Prime Capital has been announced by BenchSci, a global leader in AI solution... |
| 26.05.2023 | BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | ASCEND by BenchSci harnesses proprietary text and image-based machine learning models, empowering scientists to dramatically improve the speed and success of research at any stage of pre-clinical drug development
BenchSci, a world leader in... |
| 26.05.2023 | BenchSci raises $70M to accelerate drug discovery with AI
Your vote of support is important to us and it helps us keep the content FREE.
One-click below supports our mission to provide free, deep an... | Toronto-based artificial intelligence startup BenchSci has raised $95 million Canadian dollars, or $70 million, in funding to help scientists discover new drugs faster.
BenchSci, officially Scinapsis Analytics Inc., announced the Series D r... |
| 25.05.2023 | BenchSci Raises $70M in Series D Funding | BenchSci, a Toronto, Canada-based company which specializes in AI solutions for preclinical life sciences research and development (R&D), raised USD$70M in Series D funding.
The round, which brought the total amount to $170M, was led by... |
| 25.05.2023 | BenchSci closes $95-million CAD Series D to expand AI drug-discovery platform | - |
| 25.05.2023 | BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | - |
| 20.03.2023 | Research: What AI Talent in the UK Prioritise During a Job Search | BenchSci’s report — which was conducted in partnership with tech market research company Vanson Bourne — surveyed over 200 UK-based AI experts (including machine learning and data engineers), to glean insights regarding the current employme... |
| 13.02.2023 | BenchSci Launches ‘Map’ of Biology Research Platform for Pharmaceutical Research | What You Should Know:
ASCEND™ by BenchSci helps remove barriers that result in 98 percent of pharmaceutical research investment that fails to reach patients. The intuitive software platform empowers scientists to discover biological connect... |
| 01.02.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 1st Feb 2023 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 31.01.2023 | BenchSci Announces Launch of ASCEND a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research | The SaaS solution is powered by proprietary machine-learning technology that reads and interprets data like a PhD scientist
BenchSci, a world leader in AI solutions for drug discovery, announced the launch of its latest technology, ASCEND b... |
| 24.01.2022 | BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform | Toronto, Canada, Jan. 24, 2022 (GLOBE NEWSWIRE) -- BenchSci, a global leader in machine learning applications for novel medicine development, today announced a $63 million Series C (US $50 Million) funding round led by Inovia Capital and TC... |
| 24.01.2022 | BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform | Led by Inovia Capital and TCV, funding brings total investment to $123 million and will expedite expansion of machine learning technology used in 16 of the top 20 pharmaceutical companies
Toronto, Canada, Jan. 24, 2022 (GLOBE NEWSWIRE) -- B... |
| 24.01.2022 | AI firm BenchSci raises $50M for tech that takes waste out of preclinical research | BenchSci claims its artificial intelligence technology teaches computers to read and think like a Ph. D. scientist. The young company has placed this software in the hands of pharmaceutical companies and research institutions, and it now ha... |
| 12.08.2021 | Vanessa Ribreau Joins BenchSci as Chief People Officer To Lead Company’s Embrace Of The Future Of Work | In the Face of Unprecedented Workplace Changes, Senior HR Leader Will Continue the Evolution of BenchSci’s Progressive and Award-Winning Culture
Toronto-based hypergrowth startup BenchSci announced the appointment of Vanessa Ribreau as Chie... |
| 21.12.2020 | Why Covid Will Make AI Go Mainstream In 2021: Top 3 Trends For Enterprises | 3 Big Ideas for 2021getty |
| 19.10.2020 | AI drug-discovery firm lands first partnership | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 26.05.2020 | Investors shower AI drug discovery startups with over $200M in new funding | |
| 15.04.2020 | Molecule-in-21-days AI startup Insilico adds Boehringer to list of Big Pharma partners | Seven months after their headline-grabbing Nature Biotechnology study and in the throes of a Covid-19 research effort, Hong Kong-based AI startup Insilico Medicine has nabbed a new Big Pharma partner: Boehringer Ingelhei... |
| 05.03.2020 | YC-backed Turing uses AI to help speed up the formulation of new consumer packaged goods | One of the more interesting and useful applications of artificial intelligence technology has been in the world of biotechnology and medicine, where now more than 220 startups (not to mention universities and bigger pharma companies) are us... |
| 04.02.2020 | BenchSci Raises $22M in Series B Funding | BenchSci, a Toronto, Canada-based provider of a machine learning platform to identify and resolve preclinical research inefficiencies in drug discovery, raised $22m in Series B financing.
The round was led by F-Prime Capital, with participa... |
| 04.02.2020 | BenchSci raises $29 million CAD Series B round | BenchSci has raised a $29 million CAD ($22 million USD) Series B funding round led by F-Prime Capital.
The financing round also saw participation from Venture Capital Catalyst Initiative (VCCI) – backed Northleaf Capital Partners and return... |
| 19.12.2019 | Is Blockchain the Shot in the Arm Healthcare Needs? | This post is part of CoinDesk's 2019 Year in Review, a collection of 100 op-eds, interviews and takes on the state of blockchain and the world. Dr. Alex Cahana is head of healthcare and blockchain consulting at Genesis Block.
At the end of ... |
| 03.12.2019 | AI drug discovery firm spins out of Stanford research | Like many AI-wielding firms, the startup hopes to speed up the drug-discovery process with an eye on severe and debilitating diseases for which medicine is scarce. The firm plans to partner with pharma companies to bring candidates to marke... |
| 09.10.2019 | AI Startup Working To Target Cancer, Age-Related Disease Gets $37 Million Nod From Top VCs | - |
| 02.10.2019 | Trade agreement drug monopoly is obsolete given faster, better drug discovery | For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its government-protected monopolies would have detrimental effects on innovation. Members of Congress on both sides of the aisle have take... |
| 22.08.2019 | AI startups are racing into drug development. Here’s 5 burning questions about which will survive | SAN FRANCISCO — About two years ago, Simon Smith started counting the startups trying to bring artificial intelligence to drug development. Smith, an AI startup executive himself, found about 30 of them. Now? His tally is up to 148.
Smith’s... |
| 26.06.2019 | BenchSci’s total funding reaches $27 million as Gradient ups investment | Toronto-based BenchSci, an AI biomedical startup, has raised approximately $6.7 million CAD in financing, bringing its total funding to $27 million CAD ($20 million USD).
“Given the amount of data consumed and generated in drug discovery, A... |
| 09.11.2018 | AI in drug development and personalized medicine | Medicine and other scientific areas have always used computing power wherever they could find it-- to help modeling go faster and arrive at viable drugs more quickly.
But when we apply the most recent advancements in artificial intelligence... |
| 27.09.2018 | Idx raises $33 million for AI diagnostic systems that detect eye disease and other conditions | Artificial intelligence (AI) is emerging as a key tool in just about every industry, from marketing to recruitment and beyond. But one particularly powerful application for AI is in health care, where we’re already seeing early signs of its... |
| 27.09.2018 | Idx raises $33 million for AI diagnostic systems that detect eye disease and other conditions | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Artificial intelligence (AI) is emerging as a key tool in just about every industry, from marketing to recruitment and beyond. But one ... |
| 05.05.2018 | AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery | To enable the machine learning, we will use high-quality data that has already been collected, but we will also invest heavily in the creation of our own datasets using high throughput experimental approaches, datasets that are designed exp... |
| 02.05.2018 | Google’s AI-focused Gradient Ventures invests in BenchSci to speed up biomedical discoveries | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
BenchSci, an AI-powered search engine for biomedical researchers, has raised $8 million in a series A round of funding led by iNovia Ca... |
| 02.05.2018 | BenchSci Raises US$8M in Series A Funding | BenchSci, a Toronto, Canada-based AI-powered search engine for biological products, raised US$8m in Series A financing.
The round was led by iNovia Capital with participation from Google’s AI-focused venture fund, Gradient Ventures, and ret... |
| 02.05.2018 | BenchSci raises $10 million Series A for antibody search engine | Toronto-based BenchSci, a search engine to help researchers find antibody usage data, has raised a $10 million Series A round, led by iNovia Capital.
The round included participation from Google’s AI-focused venture fund, Gradient Ventures,... |
| 02.05.2018 | Term Sheet — Wednesday, May 2 | 5 Qs WITH A DEALMAKER
In February, Reddit co-founder Alexis Ohanian said he would step down from his daily role at the company to return to investing.
Paid Content You can't secure what you can't see From ExtraHop
“I still use Reddit to dis... |
| 02.05.2018 | Google’s AI-focused Gradient Ventures invests in BenchSci to speed up biomedical discoveries | BenchSci, an AI-powered search engine for biomedical researchers, has raised $8 million in a series A round of funding led by iNovia Capital, with participation from Google’s recently announced Gradient Ventures, Golden Venture Partners, Af... |
| 19.03.2018 | Bioinformatics startup twoXAR bags $10M in Series A | JP Lee, managing director of SoftBank Ventures, will join Andreessen Horowitz general partner Vijay Pande on the twoXAR board of directors. Palo Alto, California-based twoXAR reached this next stage of growth thanks to $3.4 million in seed ... |
| 24.01.2017 | Chan Zuckerberg Initiative acquires AI startup | Through partnerships with publishers of scientific journals, Meta created a tool that is used by 1,200 institutes, according to a blog entry on the company’s website. Meta seeks to address a challenge faced by the life science community and... |
| - | AI drug discovery firm spins out of Stanford research | The crowd of companies tapping artificial intelligence to discover new drugs is continuing to grow.
Among the latest entrants is Genesis Therapeutics, which formally launched recently on the back of $4.1 million in seed funding from some we... |
| - | AI firm BenchSci raises $50M for tech that takes waste out of preclinical research | BenchSci claims its artificial intelligence technology teaches computers to read and think like a Ph. D. scientist. The young company has placed this software in the hands of pharmaceutical companies and research institutions, and it now ha... |
| - | AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery | A former Stanford University researcher who served as chief computing officer at Alphabet anti-aging business Calico Labs has launched a startup of her own. In a Medium blog post, Daphne Koller offered an overview of her new business, insit... |
| - | Chan Zuckerberg Initiative acquires AI startup | Mark Zuckerberg and Dr. Priscilla Chan
More than a year after Facebook CEO and Cofounder Mark Zuckerberg and his wife, pediatrician Dr. Priscilla Chan, set up a philanthropy to support healthcare, social justice and other issues, the Chan Z... |
| - | AI drug-discovery firm lands first partnership | Roche Group subsidiary Genentech has tapped a startup drug-discovery firm to find potential drug candidates for a variety of diseases.
The deal with Genesis Therapeutics includes an upfront payment and a series of milestone payments as well... |
| - | BenchSci | “BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.” |
| - | Bioinformatics startup twoXAR bags $10M in Series A | Bioinformatics-based startup twoXAR has built some bank with $10 million in Series A financing from a trio of firms, the company announced Monday. Leading this Series A infusion is SoftBank Ventures, with Andreessen Horowitz and OS Fund rou... |
